Cruz-Haces, Marcela
Tang, Jonathan
Acosta, Glen
Fernandez, Joseph
Shi, Riyi http://orcid.org/0000-0002-7297-9428
Funding for this research was provided by:
Indiana Clinical and Translational Sciences Institute
National Institute of Neurological Disorders and Stroke
Article History
Received: 4 January 2017
Accepted: 27 June 2017
First Online: 11 July 2017
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Riyi Shi is the co-founder of Neuro Vigor, a start-up company with business interests of developing effective therapies for CNS neurodegenerative diseases and trauma. The other authors declare they have no competing interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.